Revance Therapeutics shares owned by Lindbrook Capital
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Lindbrook Capital
from 13F filings
Historical chart of Lindbrook Capital investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Lindbrook Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $433 | 88 | 4.92 |
| 2023-12-31 | $1.1k | 123 | 8.79 |
| 2023-09-30 | $3.1k | 274 | 11.47 |
| 2023-06-30 | $3.3k | 131 | 25.31 |
| 2023-03-31 | $4.2k | 131 | 32.21 |
| 2022-12-31 | $3.5k | 191 | 18.46 |
| 2022-09-30 | $5.0k | 191 | 26.18 |
| 2022-06-30 | $2.0k | 161 | 12.42 |
| 2022-03-31 | $3.0k | 161 | 18.63 |
| 2021-12-31 | $2.0k | 124 | 16.13 |
| 2021-09-30 | $2.0k | 88 | 22.73 |
| 2021-06-30 | $3.0k | 88 | 34.09 |
| 2021-03-31 | $2.0k | 88 | 22.73 |
| 2020-12-31 | $2.0k | 88 | 22.73 |